🏥
🏥 Health
GLP-1 Drugs Are Reshaping US Healthcare – Should Everyone Take Them?
GLP-1 drugs, originally developed to treat diabetes, are now widely prescribed for obesity and are fundamentally reshaping healthcare in the United States. Their surging popularity has sparked debate over how broadly they should be prescribed and what the long-term consequences may be. Experts and policymakers are questioning whether the drugs should be available to the general population or reserved for specific medical cases.
Comments
1 in the thread
Comments
Join the discussion — what's your take?
No comments yet. Be the first!
każdy powinien brać, każdy powinien płacić, wszyscy szczęśliwi. firma zadowolona
Report